Shares of Abacus Life, Inc. (ABL) have gained 2.3% over the past four weeks to close the last trading session at $7.72, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.38 indicates a potential upside of 86.3%.The mean estimate comprises four short-term price targets with a standard deviation of $1.80. While the lowest estimate of $13 indicates a 68.4% increase from the curre ...